Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis

Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis

US Patent 11007192 · Granted May 18, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione2024
Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione2024
Method for solubilizing poorly water-soluble dietary supplements and pharmaceuti2022
Method for solubilizing poorly water-soluble dietary supplements and pharmaceuti2022
Method for solubilizing poorly water-soluble cosmetic agents2021
Methhod for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-d2021
Methhod for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-d2021
Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione2021
Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione2021
Agents for the treatment of retroviral infectious diseases2020
Agents for the treatment of retroviral infectious diseases2020
Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharma2019